Neuropsychiatric illness in systemic lupus erythematosus: Insights from a patient with erotomania and Geschwind's syndrome

American Journal of Psychiatry

Volumn 167, Issue 5, 2010, Pages 502-507

  Wright, Mark T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CARBAMAZEPINE; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; HALOPERIDOL; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LORAZEPAM; PHENYTOIN; PREDNISONE; RISPERIDONE; SERTRALINE; ZIPRASIDONE;

ACADEMIC ACHIEVEMENT; ADD ON THERAPY; ADULT; AGITATION; ANHEDONIA; ANTIBODY SCREENING; ANTIBODY TITER; ANTICOAGULANT THERAPY; APATHY; ARTHRITIS; ASCITES; BEDTIME DOSAGE; BRAIN EDEMA; CASE REPORT; CATATONIA; COGNITION; CONFERENCE PAPER; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EROTOMANIA; FEMALE; FOLLOW UP; GESCHWIND SYNDROME; GRAND MAL SEIZURE; HEMATURIA; HEMOLYTIC ANEMIA; HOSPITAL READMISSION; HUMAN; HYPERSEXUALITY; IMPULSIVENESS; INSOMNIA; LABORATORY TEST; LEUKOCYTE COUNT; LOW DRUG DOSE; MEMORY DISORDER; MENTAL DETERIORATION; MENTAL DISEASE; MENTAL HOSPITAL; MORNING DOSAGE; MYALGIA; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PANCREATITIS; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PERICARDIAL EFFUSION; PERSEVERATION; PERSONALITY DISORDER; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; PSYCHIATRY; PSYCHOSIS; RASH; RELIGION; REMISSION; SCHIZOPHRENIA; SEDIMENTATION RATE; SPEECH DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL LOBE EPILEPSY; THOUGHT DISORDER; TONIC CLONIC SEIZURE; TREATMENT PLANNING; TREATMENT WITHDRAWAL; WEANING;

ADULT; ANTIPSYCHOTIC AGENTS; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PSYCHOTIC DISORDERS; RELIGION; SEXUAL BEHAVIOR; SYNDROME;

EID: 77951832855     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09040487     Document Type: Conference Paper

References (41)

1. de Clerambault GG: Les délires passionnels: érotomanie, revendication, jalousie (présentation de malade). Bulletin de la Société Clinique de Médecine Mentale 1921; 9:61-71
2. Brune M: De Clerambault's syndrome (erotomania) in an evolutionary perspective. Evol Hum Behav 2001; 22:409-415
3. Seeman MV: Delusional loving. Arch Gen Psychiatry 1978; 35:1265-1267
4. Gillett T, Eminson SR, Hassanyeh F: Primary and secondary erotomania: clinical characteristics and follow-up. Acta Psychiatr Scand 1990; 82:65-69 (Pubitemid 20244544)
5. Ellis P, Mellsop G: De Clerambault's syndrome: a nosological entity? Br J Psychiatry 1985; 146:90-93
6. Kennedy N, McDonough M, Kelly B, Berrios GE: Erotomania revisited: clinical course and treatment. Compr Psychiatry 2002; 43:1-6 (Pubitemid 34056268)
7. Anderson CA, Camp J, Filley CM: Erotomania after aneurysmal subarachnoid hemorrhage: case report and literature review. J Neuropsychiatry Clin Neurosci 1998; 10:330-337 (Pubitemid 28369629)
8. El Gaddal YY: De Clerambault's syndrome (erotomania) in organic delusional syndrome. Br J Psychiatry 1989; 154:714-716
9. Signer SF, Cummings JL: De Clerambault's syndrome in organic affective disorder: two cases. Br J Psychiatry 1987; 151:404-407 (Pubitemid 17139019)
10. Drevets WC, Rubin EH: Erotomania and senile dementia of Alzheimer type. Br J Psychiatry 1987; 151:400-402 (Pubitemid 17139017)
11. Brune M, Schroder SG: Erotomania variants in dementia. J Geriatr Psychiatry Neurol 2003; 16:232-234
12. Olojugba C, de Silva R, Kartsounis LD, Royan L, Carter J: De Clerambault's syndrome (erotomania) as a presenting feature of fronto-temporal dementia and motor neurone disease (FTD-MND). Behav Neurol 2007; 18:193-195
13. Waxman SG, Geschwind N: The interictal behavior syndrome of temporal lobe epilepsy. Arch Gen Psychiatry 1975; 32:1580-1586
14. Benson DF: The Geschwind syndrome. Adv Neurol 1991; 55:411-421
15. Bear DM, Fedio P: Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977; 34:454-467 (Pubitemid 8157493)
16. American College of Rheumatology, Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology Nomenclature and Case Definitions for Neuropsychiatric Lupus Syndromes. Arthritis Rheum 1999; 42:599-608
17. Fessel WJ, Solomon GF: Psychosis and systemic lupus erythematosus: a review of the literature and case reports. Calif Med 1960; 92:266-270
18. Cohen AS, Reynolds WE, Franklin EC, Kulka JP, Ropes MW, Shulman LE, Wallace SL: Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 1971; 21:643-648
19. Appenzeller S, Cendes F, Costallat LT: Acute psychosis in systemic lupus erythematosus. Rheumatol Int 2008; 28:237-243 (Pubitemid 350265464)
20. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR: Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30:985-992 (Pubitemid 36529618)
21. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo- Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, McGlasson D: Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58:1214-1220 (Pubitemid 34411865)
22. Mok CC, Lau CS, Wong RW: Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001; 28:766-771 (Pubitemid 32246944)
23. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317:265-271 (Pubitemid 17100105)
24. Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, van Vollenhoven R, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcón GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT: Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008; 58:843-853 (Pubitemid 351364883)
25. Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IE, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JP: Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006; 54:312-324
26. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B: Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA 2006; 103:678-683
27. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G: Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti- endothelial-cell antibodies. Arthritis Res Ther 2004; 6:R366-R372
28. Hanly JG: Neuropsychiatric lupus. Rheum Dis Clin North Am 2005; 31:273-298
29. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Oqino T: Interferon-alpha in lupus psychosis. Arthritis Rheum 1992; 35:417-422
30. Tassiulas IO, Boumpas DT: Clinical features and treatment of systemic lupus erythematosus, in Kelley's Textbook of Rheumatology, 8th ed. Edited by Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS. Philadelphia, WB Saunders, 2008, chap 75
31. Hanly JG, McCurdy G, Fouqere L, Douglas JA, Thompson K: Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004; 31:2156-2162
32. Haserick JR: Modern concepts of systemic lupus erythematosus: a review of 126 cases. J Chronic Dis 1955; 1:317-334
33. Hanly JG, Hong C, Smith S, Fisk JD: A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42:728-734
34. Hermosillo-Romo D, Brey RL: Neuropsychiatric involvement in systemic lupus erythematosus. Curr Rheumatol Rep 2002; 4:337-344
35. Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, Origgi L, Vanoli M, Gambini O, Vanzulli L, Croce D, Campana A, Messa C, Fazio F, Tincani A, Anzola G, Cattaneo R, Padovani A, Gasparotti R, Gerli R, Quartesan R, Piccirilli M, Farsi A, Emmi E, Passaleva A: Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999; 8:11-19
36. Sibbitt WL, Sibbitt RR, Brooks WM: Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999; 42:2026-2038
37. Postiglione A, Milan G, Pappata S, De Falco C, Lamenza F, Schiat tarella V, Gallotta G, Sorrentino P, Striano S: Fronto-temporal dementia presenting as Geschwind's syndrome. Neuro-case 2008; 14:264-270
38. Van Vugt P, Paquier P, Kees L, Cras P: Increased writing activity in neurological conditions: a review and clinical study. J Neurol Neurosurg Psychiatry 1996; 61:510-514
39. Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994; 6:358-370
40. Fujii DE, Ahmed I, Takeshita J: Neuropsychologic implications in erotomania: two case studies. Neuropsychiatry Neuropsychol Behav Neurol 1999; 12:110-116
41. McKeon A, Marnane M, O'Connell M, Stack JP, Kelly PJ, Lynch T: Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Arch Neurol 2007; 64:1528-1530